-
Orthofix Q1 sales bring mild growth: 6 notes
Orthofix on May 6 posted a slight revenue increase in the first quarter of 2022. -
Competitors challenge Medtronic's lead in the spine robot market
More than a decade after the first spine surgical robot was launched, Medtronic is still considered the market leader, but smaller device companies could chip away at its market share as they launch their own platforms and adoption increases among surgeons. -
Alphatec sees 61% revenue jump, more surgeon adoption in Q1: 4 notes
Alphatec saw a revenue leap in the first quarter of 2022, according to financial results posted May 5. -
ZimVie's spine sales fall 13.9% in Q1: 5 notes
Zimmer Biomet's spine and dental spinoff company, ZimVie, dipped in its first quarter revenue and spine sales, according to results posted May 5. -
Stryker appoints new leader for orthopedic, spine business
Preston Wells, vice president of investor relations at Stryker, was appointed vice president and group CFO for the devicemaker's spine and orthopedic business. -
AI and AR-powered spinal guidance system debuts
Surgalign's artificial intelligence and augmented reality surgical guidance system was debuted at Indiana Spine Hospital in Carmel, Ind. -
Accelus launches interbody cage for endoscopic, minimally invasive spinal fusion
Accelus launched its TiHawk7 interbody cage for endoscopic and minimally invasive lumbar fusions. -
NuVasive's Pulse surpasses 500 cases; robotics will be a 'key application'
NuVasive's Pulse integrated spine surgery system was a key growth driver in the first quarter and has been used in more than 500 commercial cases, the company said in its first-quarter earnings call May 4, according to Seeking Alpha. -
Stryker promotes new board leadership
Stryker promoted two members of its board of directors to leadership positions. -
NuVasive posts 7.2% revenue increase in Q1: 4 notes
NuVasive on May 4 posted revenue growth in the first quarter of 2022 and almost $20 million in net profit. -
Wenzel Spine names CEO, SeaSpine's new leadership and more: 9 device company notes
Camber Spine's latest patent and eight more updates from spine and orthopedic devicemakers in the last week: -
SeaSpine sees 21% revenue jump in Q1, names new leadership
SeaSpine's first-quarter sales grew across its spinal implants and orthobiologics, and the company named new leadership. -
4 technologies exciting spine surgeons
Innovation continues to pick up steam across the spine industry as surgeons look for more minimally invasive methods to operate on their patients, reduce the risk of complications and accelerate recovery. -
New leadership steps in at Wenzel Spine after former CEO's death
Wenzel Spine appointed William Wilson as CEO almost two months after the devicemaker's former CEO died. -
Spine devicemaker's partnership aims to improve reimbursement
Genesys Spine is partnering with Pria Healthcare to improve patient coverage for its sacroiliac joint fusion products. -
Devicemaker launches spine surgical access system
Spine devicemaker TeDan Surgical released a surgical access system designed for anterior approaches. -
Smith+Nephew has 'encouraging start' to 2022, sports medicine grows 10% in Q1
Smith+Nephew saw a slight revenue uptick in the first quarter of 2022; however, its sports medicine and joint repair segment jumped with double-digit growth. -
Who is Globus Medical's new CEO? 5 things to know
Daniel Scavilla is the new CEO of Globus Medical, succeeding Dave Demski, who stepped down to pursue other opportunities after 20 years with the company. -
Stryker's spine, orthopedic sales grow 5.1% in Q1: 5 notes
Stryker on April 28 posted $4.3 billion in first-quarter net sales and saw 5.1 percent growth in its orthopedics and spine business. -
Camber Spine snags 47th patent allowance
Camber Spine received a notice of allowance from the U.S. Patent and Trademark Office for its Variant Retractor.
Page 37 of 191